ArticleAnnals of hematology2024

Very long-term efficacy of venetoclax combined with hypomethylating agents in two AML elderly: is it the time for treatment discontinuation strategies?

Pasquale Niscola et al.PubMed ↗Publisher ↗

No numbers read from the abstract.